HexemBio is a groundbreaking longevity therapeutics company developing first-in-class stem cell rejuvenation technology. Backed by peer-reviewed science and published in Nature, our platform restores the regenerative power of aged blood stem cells, unlocking new possibilities in aging, immune health, and beyond. Learn more at hexemb.io
Company Details
- Employees
- 1
- Founded
- -
- Address
- 7 Pennsylvania Plaza,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.hexemb.io/
- HQ
- New York, NY
Hexembio Questions
Hexembio's website is https://www.hexemb.io/
Hexembio's LinkedIn profile is https://www.linkedin.com/company/hexembio
Hexembio has
1 employees.
View email and phone details for 1
employees at Hexembio.
Hexembio's industry is
Biotechnology Research
Hexembio's top competitors are
Caspr Biotech,
Collage Bio,
Giraffe Bio,
Potato,
Cellco - The Cell Company,
Newlimit,
Mit Female Founders Pitch Competition,
Draper Associates,
Tinkeso Therapeutics,
Syntax Bio.
Hexembio's categories are Biotechnology Research
Hexembio's founding year is 2024
